Deals

Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together
Biotech

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

For each program advanced by the Big Pharma, Vyriad will receive an upfront payment, milestone payments and royalties.
Darren Incorvaia Nov 20, 2024 12:00pm
graphic image of different colored hands shaking

Pfizer, Flagship return to obesity as part of 10-program collab

Nov 20, 2024 8:05am
gold arrow pointing upward forward

Biophama VC, deal values and exits all rise in Q3: Pitchbook

Nov 20, 2024 6:15am
radio volume channel

Novartis taps Ratio for $745M radiopharmaceutical pact

Nov 18, 2024 8:00am
Graphic of two hands shaking under a red and purple light

Biotechs behind J&J-bought Yellow Jersey partner on IBD drug

Nov 15, 2024 8:30am
Diverse group of hands holding up US dollar banknotes of various denominations on green background - stock photo

Halozyme offers $2B for Evotec to expand beyond tech used by J&J

Nov 15, 2024 6:01am